2023 annual financial data

XORTX Therapeutics Inc. 2023 Operating margin

XORTX Therapeutics Inc. 2023 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -6,156,862 USD and net income was -2,859,371 USD.
Operating cash flow was -6,583,165 USD.

Get free XORTX Therapeutics Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-6,156,862 USD
Net income
-2,859,371 USD
Operating cash flow
-6,583,165 USD